21 February 2023
: Case report 
Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report
Unknown etiology, Adverse events of drug therapy
Jayson P. Jessop1ABCDEF, Joshua Russell1ABCDEF, Adriana DeJesus1ABEF, Chandni Bardolia1ADEF, Abeer Hanna2BCD, Jacques Turgeon34ADEF*, Veronique Michaud43ABDEF, Nishita S. Amin1ABCDEFDOI: 10.12659/AJCR.938850
Am J Case Rep 2023; 24:e938850
Table 1. Medications at time of enrollment.
| Indication | Medication | Dose | Frequency |
|---|---|---|---|
| Prevention of atherosclerotic cardiovascular disease | Atorvastatin | 20 mg | Once daily |
| Ezetimibe | 10 mg | Once daily | |
| HTN, heart disease | Carvedilol | 12.5 mg | Twice daily |
| Furosemide | 20 mg | Once daily | |
| HTN, atrial fibrillation | Diltiazem | 120 mg | Twice daily |
| Endocarditis prophylaxis | Doxycycline hyclate | 100 mg | Twice daily |
| MDD | Fluoxetine | 20 mg | Once daily |
| Type II diabetes | Dulaglutide (subcutaneous) | 0.75 mg | Once weekly |
| Insulin glargine (subcutaneous) | 10 units | Three times daily | |
| Insulin aspart (subcutaneous) | 5 units | Once daily | |
| GERD | Lansoprazole | 30 mg | Once daily |
| Hypothyroidism | Levothyroxine | 200 mcg | Once daily |
| Anxiety | Lorazepam | 0.5 mg | Up to 3 times daily |
| Atrial fibrillation | Warfarin | 17.5 mg | Weekly |
| GERD – gastroesophageal reflux disease; HTN – hypertension; MDD – major depressive disorder. | |||